10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance.
Akero Therapeutics Inc. (AKRO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Alkeon Capital Management Panayotis Takis Sparaggis | 3,325,004 | $95,394,365 | -1% | 0.16% |
| 2. | Perceptive Advisors Joseph Edelman | 1,714,806 | $49,197,784 | +15% | 1.04% |
| 3. | Redmile Group Jeremy Green | 1,387,479 | $39,806,773 | -15% | 2.34% |
| 4. | Point72 Asset Management Steve Cohen | 1,303,323 | $37,392,347 | 0.09% | |
| 5. | Baker Bros. Advisors Julian Baker And Felix Baker | 1,097,082 | $31,475,283 | 0.32% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.85 | 50,000 | 800,000 | 2023-12-08 | Filing | ||
| $19.80 | 50,000 | 750,000 | 2023-12-08 | Filing | ||
| $16.99 | 50,000 | 700,000 | 2023-12-01 | Filing | ||
| $16.90 | 50,000 | 650,000 | 2023-11-30 | Filing | ||
| $42.06 | 25,000 | 600,000 | 2023-08-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.13 | 1,000 | 34,258 | 2024-12-16 | Filing | ||
| $29.11 | 9,074 | 95,648 | 2024-12-16 | Filing | ||
| $31.10 | 3,800 | 178,337 | 2024-12-17 | Filing | ||
| $31.03 | 2,450 | 178,337 | 2024-12-10 | Filing | ||
| $30.79 | 2,368 | 178,337 | 2024-12-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,122,895 | $119,619,598 | 0% | |
| 2. | 4,306,401 | $100,574,950 | 0.05% | |
| 3. | 4,180,507 | $97,614,839 | 0% | |
| 4. | 3,592,759 | $83,890,923 | 1.31% | |
| 5. | 3,085,048 | $72,035,871 | 0% |
News See All
10 Biggest Stocks with Negative Beta to Consider
Beta is a measurement of market risk or volatility that indicates how much the price of a stock tends to fluctuate up and down compared to other stocks.
10 Most Promising Small-Cap Stocks According to Hedge Funds
Small-cap stocks are offering a myriad of opportunities to investors and are expected to go higher.
10 Best Small-Cap Healthcare Stocks To Buy Now
In difficult economic times, healthcare equities are sometimes regarded as a defensive investment.
12 Most Promising Stocks to Buy According to Hedge Funds
In this article, we will take a look at the 12 most promising stocks to buy according to hedge funds.
25 Biggest Stocks with Negative Beta
Stock markets were in see-saw mode before the Fed’s September decision on rate hikes.
Wall Street Analysts See Upside Potential for 5 Stocks with Rising Price Targets
In this article, we discuss the 5 stocks receiving price-target hike from Wall Street analysts.
Hedge Fund and Insider Trading News: Bill Ackman, Tiger Global Management, Citadel LLC, Third Point LLC, Universal Logistics Holdings Inc (ULH), Akero Therapeutics, Inc. (AKRO), and More
Pershing Square's Bill Ackman isn't shy about making controversial bets.
Hedge Fund and Insider Trading News: Crispin Odey, Oceanwood Capital Management, Coatue Management, MFN Partners, Saba Capital Management, Akero Therapeutics Inc (AKRO), Yellow Corporation (YELL), and More
Freddie Neave has lowered the risk profile of Crispin Odey’s flagship fund, which he took over the management of in June, according to an investor letter seen by Reuters on Wednesday.
Billionaire Hedge Funds
